Alejandro J. Espanol
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.
Journal: Exploration of targeted anti-tumor therapy
Published: May 26, 2023
Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells.
Journal: World journal of clinical oncology
Published: December 27, 2021
Breast cancer: Muscarinic receptors as new targets for tumor therapy.
Journal: World journal of clinical oncology
Published: February 17, 2021
Corrigendum to "Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors" [Int. Immunopharmacol. 84 (2020) 106514].
Journal: International immunopharmacology
Published: June 28, 2020
Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors.
Journal: International immunopharmacology
Published: January 21, 2020
Angiogenesis signaling in breast cancer models is induced by hexachlorobenzene and chlorpyrifos, pesticide ligands of the aryl hydrocarbon receptor.
Journal: Toxicology and applied pharmacology
Published: January 20, 2020
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype.
Journal: PloS one
Published: November 25, 2019
Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy.
Journal: Current clinical pharmacology
Published: September 21, 2018
Hexachlorobenzene promotes angiogenesis in vivo, in a breast cancer model and neovasculogenesis in vitro, in the human microvascular endothelial cell line HMEC-1.
Journal: Toxicology letters
Published: May 11, 2015
Participation of non-neuronal muscarinic receptors in the effect of carbachol with paclitaxel on human breast adenocarcinoma cells. Roles of nitric oxide synthase and arginase.
Journal: International immunopharmacology
Published: February 09, 2015
The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
Journal: Biochemical pharmacology
Published: January 31, 2014
Last Updated: 09/26/2026